D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
CDW
CDW
$18.9B
| $12.7M | 0.02% |
180,249
-264,962
| -60% | -$19.3M |
|
852
Textron
TXT
$14.9B
| $12.7M | 0.02% |
214,701
-118,301
| -36% | -$6.95M |
|
853
Starbucks
SBUX
$119B
| $12.7M | 0.02% |
218,576
+160,588
| +277% | +$9.28M |
|
854
CALL
Bristol-Myers Squibb
BMY
$129B
| $12.7M | 0.02% |
200,000
-103,600
| -34% | -$6.66M |
|
855
CALL
Herbalife
HLF
$1.3B
| $12.6M | 0.02% |
258,800
-461,200
| -64% | -$19.6M |
|
856
CALL
3M
MMM
$91.8B
| $12.6M | 0.02% |
68,650
-32,173
| -32% | -$6.38M |
|
|
DYNC
857
DELISTED
Vistra Energy Corp.
DYNC
| $12.6M | 0.02% |
145,000
-30,000
| -17% | -$2.47M |
|
858
Pembina Pipeline
PBA
$29.3B
| $12.6M | 0.02% |
402,732
+275,202
| +216% | +$9.12M |
|
859
PUT
Constellation Brands
STZ
$22.5B
| $12.5M | 0.02% |
54,800
+21,000
| +62% | +$4.63M |
|
860
Neurocrine Biosciences
NBIX
$18.2B
| $12.5M | 0.02% |
150,347
+44,267
| +42% | +$3.74M |
|
861
World Kinect Corp
WKC
$2.07B
| $12.4M | 0.02% |
506,445
-27,117
| -5% | -$697K |
|
862
CALL
Freeport-McMoran
FCX
$86.2B
| $12.4M | 0.02% |
703,100
-145,500
| -17% | -$2.73M |
|
863
CALL
Cboe Global Markets
CBOE
$32.2B
| $12.3M | 0.02% |
107,900
+7,500
| +7% | +$912K |
|
|
ABMD
864
CALL
DELISTED
Abiomed Inc
ABMD
| $12.3M | 0.02% |
42,300
+20,000
| +90% | +$5.07M |
|
865
LyondellBasell Industries
LYB
$19.5B
| $12.3M | 0.02% |
116,260
+112,691
| +3,157% | +$12.6M |
|
|
B
866
Barrick Mining
B
$60.9B
| $12.3M | 0.02% |
984,811
+385,550
| +64% | +$5.13M |
|
867
PUT
Ulta Beauty
ULTA
$21.8B
| $12.3M | 0.02% |
60,000
+4,500
| +8% | +$974K |
|
|
GTS
868
DELISTED
Triple-S Management Corporation
GTS
| $12.3M | 0.02% |
492,588
+46,541
| +10% | +$1.11M |
|
869
PUT
Eli Lilly
LLY
$1.08T
| $12.2M | 0.02% |
157,900
+112,900
| +251% | +$9.09M |
|
|
MGI
870
DELISTED
MoneyGram International, Inc. New
MGI
| $12.2M | 0.02% |
1,417,274
+806,949
| +132% | +$9.02M |
|
871
Fastenal
FAST
$54.8B
| $12.2M | 0.02% |
894,084
+512,324
| +134% | +$7.05M |
|
872
Ambarella
AMBA
$3.04B
| $12.2M | 0.02% |
248,821
-153,338
| -38% | -$7.95M |
|
873
Rithm Capital
RITM
$5.58B
| $12.2M | 0.02% |
741,055
+666,331
| +892% | +$11.3M |
|
874
Abercrombie & Fitch
ANF
$4.55B
| $12.2M | 0.02% |
503,457
-302,540
| -38% | -$6.39M |
|
875
CALL
Adobe
ADBE
$105B
| $12.1M | 0.02% |
56,100
+26,100
| +87% | +$5.31M |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.